bioMerieux resumes mycoplasma kit sales
This article was originally published in Clinica
bioMerieux has restarted manufacture and sales of its Mycoplasma IST kits following a successful court appeal. The Lyon Appeals Court quashed a ruling made by the Lyon High Court last September, declaring null and void three claims of the patent infringement case brought by fellow French manufacturer International Microbio and its holding company DBV. bioMerieux told Clinica it will be seeking a refund of the Fr 900,000 ($180,000) it was ordered to pay DBV following the original court decision.